199 related articles for article (PubMed ID: 7516371)
1. [Androgen deprivation in benign prostatic hypertrophy].
Tenaglia R; Nicolai M; Di Federico G; Iantorno R; Zezza A; Lombardi G
J Urol (Paris); 1993; 99(6):296-8. PubMed ID: 7516371
[TBL] [Abstract][Full Text] [Related]
2. [Non-surgical treatment of benign prostatic hypertrophy. Current status of the problem].
Van Cangh PJ
Bull Mem Acad R Med Belg; 1992; 147(1-2):125-35; discussion 135-7. PubMed ID: 1384903
[TBL] [Abstract][Full Text] [Related]
3. Medical and nonmedical therapies for benign prostatic hypertrophy.
Loughlin KR
Geriatrics; 1991 Jun; 46(6):26-31, 34. PubMed ID: 1710196
[TBL] [Abstract][Full Text] [Related]
4. [Hormonal therapy of benign prostatic hyperplasia].
Horninger W; Bartsch G
Urologe A; 1995 Jan; 34(1):9-15. PubMed ID: 7533450
[TBL] [Abstract][Full Text] [Related]
5. [Current therapy of benign prostatic hypertrophy].
Rist M
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):875-6. PubMed ID: 2426754
[No Abstract] [Full Text] [Related]
6. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation.
Cardillo M; Berchem G; Tarkington MA; Krajewski S; Krajewski M; Reed JC; Tehan T; Ortega L; Lage J; Gelmann EP
J Urol; 1997 Jul; 158(1):212-6. PubMed ID: 9186362
[TBL] [Abstract][Full Text] [Related]
7. [Indications of antiandrogens in benign hyperplasia of the prostate].
Benassayag E
J Urol (Paris); 1995; 101(2):109-10. PubMed ID: 8522854
[No Abstract] [Full Text] [Related]
8. Overview of current status of total androgen deprivation in metastasized prostate cancer.
Debruyne FM; Witjes WP
Eur Urol; 1993; 24 Suppl 2():67-71. PubMed ID: 8262129
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of prostatic carcinoma with cyproterone acetate].
Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1996; 49(1):12-5. PubMed ID: 8975080
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacotherapy in benign prostatic hyperplasia].
Hauri D
Ther Umsch; 1995 Jun; 52(6):378-82. PubMed ID: 7541566
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
12. [Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
Umeda K
Hinyokika Kiyo; 1991 Nov; 37(11):1429-33. PubMed ID: 1722628
[TBL] [Abstract][Full Text] [Related]
13. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
14. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
15. [Results of the effectiveness of long-term treatment of patients with benign prostatic hyperplasia].
Tkachuk VN; Al'-Shukri SKh; Luk'ianov AE
Urologiia; 2002; (2):11-3. PubMed ID: 12077812
[TBL] [Abstract][Full Text] [Related]
16. [Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery].
Granados EA
Arch Esp Urol; 1998 Sep; 51(7):675-9. PubMed ID: 9807893
[TBL] [Abstract][Full Text] [Related]
17. [Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results].
Kanimoto Y; Okada K
Hinyokika Kiyo; 1991 Nov; 37(11):1423-8. PubMed ID: 1722627
[TBL] [Abstract][Full Text] [Related]
18. Medical management of benign prostatic hyperplasia.
Gray M; Allensworth D
Urol Nurs; 1997 Dec; 17(4):137-41. PubMed ID: 9451241
[No Abstract] [Full Text] [Related]
19. [Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH].
Noguchi K; Takeda M; Hosaka M; Kubota Y
Hinyokika Kiyo; 2002 May; 48(5):269-73. PubMed ID: 12094708
[TBL] [Abstract][Full Text] [Related]
20. Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection.
Oesterling JE; el Etreby MF; Gormley GJ; Imperato-McGinley JL; Roehrborn CG; Schröder FH; Tunn UW
Prog Clin Biol Res; 1994; 386():231-50. PubMed ID: 7528391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
